Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

New factor Xa inhibitors in early development at Morphochem

Oct. 24, 2002

New factor VIIa inhibitors in early development at Chugai

Oct. 23, 2002

Bayer researchers describe novel factor Xa inhibitors

Oct. 21, 2002

Merck scientists present two series of thrombin inhibitors

Oct. 16, 2002

New factor Xa inhibitors in development at Lilly

Oct. 15, 2002

Angiomax receives clearance in Canada

Oct. 11, 2002

Factor Xa inhibitors in early development at Boehringer Ingelheim

Oct. 10, 2002

Neutralase phase III protocol submitted

Oct. 9, 2002

Pharmion launches Innohep

Oct. 8, 2002

Bristol-Myers Squibb patent covers novel factor Xa inhibitors

Oct. 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.